Tullia C. Bruno, an assistant professor in School of Medicine’s Department of Immunology and a UPMC Hillman Cancer Center immunologist, has been presented with the Sy Holzer Endowed Immunotherapy Research Fund Award to advance innovative research in cancer.
Bruno’s work focuses on developing cancer therapeutics that harness the power of the immune system. More specifically, her research team focuses on B cells and tertiary lymphoid structures within the tumor microenvironment to improve the number of patients who respond favorably to immunotherapy.
The Holzer Fund, now in its fourth year, was established to honor Sy Holzer’s philanthropic work as the long-time president of PNC and his many years of service as chair of UPMC Hillman Cancer Center Council. This award, once again, is being matched by the Stanley M. Marks Endowed Research Fund at UPMC Hillman Cancer Center.
Bruno received her bachelor’s degree in chemistry at Vanderbilt University and then earned her Ph.D. in immunology from Johns Hopkins School of Medicine and completed her postdoctoral fellowship at the University of Colorado School of Medicine.